|
Garcia de Guadiana-Romualdo L, Cerezuela-Fuentes P, Espanol-Morales I, Esteban-Torrella P, Jimenez-Santos E, Hernando-Holgado A, Albaladejo-Oton MD. Prognostic value of procalcitonin and lipopolysaccharide binding protein in cancer patients with chemotherapy-associated febrile neutropenia presenting to an emergency department. Biochem Med (Zagreb). 2019 Feb 15;29(1):010702. doi: 10.11613/BM.2019.010702. Epub 2018 Dec 15. PubMed PMID: 30591812; PubMed Central PMCID: PMC6294152.
AÑO: 2019; IF: 2.114
|
30591812
|
Garcia de Guadiana-Romualdo L, Jimenez-Santos E, Cerezuela-Fuentes P, Espanol-Morales I, Berger M, Esteban-Torrella P, Hernando-Holgado A, Albaladejo-Oton MD. Analyzing the capability of PSP, PCT and sCD25 to support the diagnosis of infection in cancer patients with febrile neutropenia. Clin Chem Lab Med. 2019 Mar 26;57(4):540-548. doi: 10.1515/cclm-2018-0154. PubMed PMID: 30240355.
AÑO: 2019; IF: 3.595
|
|
Ciruelos EM, Diaz MN, Isla MD, Lopez R, Bernabe R, Gonzalez E, Cirauqui B, Coves J, Morales S, Arcediano A, Barneto I, Cerezuela P, Illarramendi JJ, Morales C, Ponce S. Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer. Eur J Cancer Care (Engl). 2019 Nov;28(6):e13164. doi: 10.1111/ecc.13164. Epub 2019 Sep 30. PubMed PMID: 31571304.
AÑO: 2019; IF: 2.161
|
|
Esquerdo G, Doménech M, López P, Pedro C, Villadiego K, Constenla M, Sánchez-Rovira P, Gasquet JA, Rodríguez CA; AVANT study group. Darbepoetin alfa administered once every three weeks for the treatment of anemia in elderly patients with non-myeloid tumors receiving chemotherapy. Tumori. 2014 Mar-Apr;100(2):225-31. doi: 10.1700/1491.16423. PubMed PMID: 24852870.
AÑO: 2014; IF: 1.234
|
|
Encarnacion JA, Cerezuela P, Espanol I, Garcia MR, Manso C, De la Fuente I, Garrigos N, Viney A, Minguillon J, Surralles J. Fanconi-like anemia related to a FANCM mutation. Eur J Med Genet. 2022 Jan;65(1):104399. doi: 10.1016/j.ejmg.2021.104399. Epub 2021 Nov 15. PubMed PMID: 34793962.
AÑO: 2022; IF: 1.9
|